Do Analysts Count on Thoughts Medication (MindMed) Inc (MNMD) Inventory to Rise After It Is Decrease By -23.23% in a Month?

Wall Street is positive about Mind Medicine (MindMed) Inc (MNMD). On average, analysts give MNMD a Strong Buy rating. The average target price is $ 8, which means analysts expect the stock to gain 426.32% over the next twelve months. That average ranking gives MNMD an analyst rating of 74, which is better than 74% of the stocks, based on data compiled by InvestorsObserver.

Wall Street analysts rate MNMD as a strong buy today. Find out what that means for you and get the rest of the rankings on MNMD!

Why are analyst ratings important?

A thorough study of a company’s underlying health can be an extremely useful resource in making investment decisions. Analysts observe companies’ growth prospects and projected earnings for a comprehensive view of specific industries. This data enables traders to act before numbers are officially reported. InvestorsObserver takes the evaluations of these analysts and evaluates these average values. This allows you to compare stocks extensively and in greater detail than the usual buy / hold / sell ratings.

What happens to Mind Medicine (MindMed) Inc stock today?

Mind Medicine (MindMed) Inc (MNMD) stock trades at $ 1.52 on Thursday, December 30th at 10:57 a.m., up $ 0.03, or 2.36%, from its previous closing price of Jan. , 48 USD. The stock traded between $ 1.39 and $ 1.53 today. Volume is easy today. To date, 1,288,162 shares have been traded, compared to an average volume of 3,692,274 shares. For the full stock report for Mind Medicine (MindMed) Inc. stock, click here.

Comments are closed.